retatrutide approval FDA Status: August 2026 Update retatrutide investigational drug review Retatrutide,

Dispense data may not capture all medication fills until a clinical encounter has occurred

Mounjaro can make oral contraceptives less effective, particularly during the first 4 weeks, and then for 4 weeks after any dose increase

However, the recent heightened social media attention on GLP-1 RAs, notably semaglutide and liraglutide, may have resulted in an imbalanced surge in reporting relative to other pharmaceuticals

Shibahara, S., Sato, M., Muller, R

NHS access requires meeting specific BMI and comorbidity criteria through NICE guidance, with prescription via specialist weight management services, though availability may be limited by supply constraints